November 2017 Issue of The Pathologist

No computer can replace the judgment of a skilled pathologist – but it can save time and resources

Mutation of which gene most likely accounts for the pathologic changes seen in this biopsy?

Population databases may be an ineffective tool for non-European patients

Guidelines recommend the Pap smear and HPV testing for cervical cancer – but are both necessary?

Metal speciation in cerebrospinal fluid may bring new understanding of neurodegenerative diseases

Can the microbiome predict the likelihood of chemotherapy side effects?

Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients

Are single-cell diagnostics needed to reveal the full picture in breast cancer?

New devices for detecting tuberculosis may speed up diagnosis and improve treatment

Users agree that biobanks aren’t delivering – but what’s wrong, and how can it be fixed?

It could actually be our strongest ally, but only if we get on board fast

As a qualitative assay, immunohistochemistry does the job. But do we need more?

So you want to transition to digital pathology. How will you store and share images?

With so many data storage and sharing possibilities, how can we match infrastructure to needs?

Every successful digital pathologist needs the support of the right infrastructure

Can two new biomarker assays offer a superior alternative to current AKI tests?

A new grading system for prostate carcinoma – and how you can adopt it in your laboratory

The hazard of over-testing in hospitalized patients is very real – but how do we change this?

Pediatric pathology is suffering from a lack of new members - why?

Ian Cree, Head, WHO Classification of Tumors Group, International Agency for Research on Cancer